MedTrace Logo

Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)

NCT01305148 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3800

Last updated 2015-08-31

No results posted yet for this study

Summary

The WARFARIN Study is a clinical trial designed to determine if the use of genetic information related to warfarin sensitivity can help create a dose of warfarin that will result in less hospitalizations and deaths related to warfarin.

Conditions

Interventions

DEVICE

Warfarin GenoSTAT Test

Use of genetic information from the GenoSTAT test to determine the warfarin dose

Sponsors & Collaborators

  • Iverson Genetic Diagnostics, Inc.

    lead INDUSTRY

Principal Investigators

  • An Pang Chieng, MD · Alhambra Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01305148 on ClinicalTrials.gov